+987.9%
MRNA vs CP
+35.2%
+952.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.5% | +9.6% | +11.9% |
| 7D | +20.6% | +5.6% | +15.1% | +18.6% |
| 30D | +27.1% | +10.0% | +17.1% | +22.8% |
| 3M | +353.4% | +4.4% | +349.0% | +352.2% |
| 6M | +446.3% | +14.1% | +432.2% | +423.8% |
| YTD | +776.2% | +29.1% | +747.1% | +684.8% |
| 1Y | +987.9% | +34.6% | +953.4% | +819.2% |
| All | +987.9% | +35.2% | +952.7% | +819.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CP.
Daily Out/Under-Performance
Portfolio return minus CP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling